Buprenorphine and Naloxone Sublingual Film 8 mg/2 mg
REMS Prescribing Information/Medication Guide Safety Sheet Product Overview NDC: Unit Size/Quantity: Indication: Buprenorphine and naloxone sublingual film is indicated for treatment of opioid dependence. Buprenorphine and naloxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support. Please see full Prescribing Information for more information. Markings: Orange-white to […]
Methadone HCl 10 mg/mL Concentrate – 4L (Cherry-flavored)
Prescribing Information Safety Sheet Product Overview NDC: Unit Size/Quantity: Indication: Methadone hydrochloride oral concentrate is an opioid agonist indicated for the: Detoxification treatment of opioid addiction (heroin or other morphine-like drugs). Maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services. Limitations of Use Methadone products used […]
Mycophenolate Mofetil for Oral Suspension, USP
REMS Prescribing Information/Medication Guide Safety Sheet NDC: Unit Size/Quantity: Indication: For the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. Please see full Prescribing Information for more information. Storage and Handling: Store dry powder at 20°C […]
Buprenorphine Sublingual
2 mg Tablet
REMS Prescribing Information/Medication Guide Safety Sheet NDC: Unit Size/Quantity: Indication: Buprenorphine sublingual tablets is indicated for the treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. Please see full Prescribing Information for more information. Markings: White, […]
Buprenorphine Sublingual
8 mg Tablet
REMS Prescribing Information/Medication Guide Safety Sheet NDC: Unit Size/Quantity: Indication: Buprenorphine sublingual tablets is indicated for the treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. Please see full Prescribing Information for more information. Markings: White, […]
Buprenorphine and Naloxone Sublingual 8 mg/2 mg Tablet
REMS Prescribing Information/Medication Guide Safety Sheet Product Overview NDC: Unit Size/Quantity: Indication: Buprenorphine and naloxone sublingual tablet contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablet should be used as part of a treatment plan that includes counseling […]
Buprenorphine and Naloxone Sublingual 2 mg/0.5 mg Tablet
REMS Prescribing Information/Medication Guide Safety Sheet Product Overview NDC: Unit Size/Quantity: Indication: Buprenorphine and naloxone sublingual tablet contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablet should be used as part of a treatment plan that includes counseling […]
Buprenorphine and Naloxone Sublingual Film 12 mg/3 mg
REMS Prescribing Information/Medication Guide Safety Sheet Product Overview NDC: Unit Size/Quantity: Indication: Buprenorphine and naloxone sublingual film is indicated for treatment of opioid dependence. Buprenorphine and naloxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support. Please see full Prescribing Information for more information. Markings: Orange-white to […]
Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg
REMS Prescribing Information/Medication Guide Safety Sheet Product Overview NDC: Unit Size/Quantity: Indication: Buprenorphine and naloxone sublingual film contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual film should be used as part of a treatment plan that includes counseling […]
Buprenorphine and Naloxone Sublingual Film 2 mg/0.5 mg
REMS Prescribing Information/Medication Guide Safety Sheet Product Overview NDC: Unit Size/Quantity: Indication: Buprenorphine and naloxone sublingual film contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual film should be used as part of a treatment plan that includes counseling […]
